Tapewire

Nasdaq · USD

EXEL

EXELIXIS, INC.

Export transactions ↓
Tapewire entity
3386
SEC CIK
0000939767
Parsed reports
735

Last 12 months

Inside the activity.

1 purchase rows · 32 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202518
Dec 202500
Jan 202600
Feb 2026014
Mar 202600
Apr 202600
May 202607
Jun 202602
Jul 202600
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 18, 2026 Filed Feb 21, 2026 01:36 UTC SaleCommon Stock 99,574 $44.01 $4,382,251.74
Disclosure

SEC source: 0000939767-26-000030 · wk-form4_1771637788.xml · nonDerivative · entry 2

WYSZOMIERSKI JACK L · CIK 0001023225 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 279,942

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2025.

F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.32 to $44.49. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.

F1 · balance_after: Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.

Read SEC document
February 18, 2026 Filed Feb 21, 2026 01:36 UTC Exercise / conversionCommon Stock 20,634 $19.77 $407,934.18
Disclosure

SEC source: 0000939767-26-000030 · wk-form4_1771637788.xml · nonDerivative · entry 1

WYSZOMIERSKI JACK L · CIK 0001023225 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 379,516

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 01:49 UTC SaleCommon Stock 30,617 $43.67 $1,337,044.39
Disclosure

SEC source: 0000939767-26-000028 · wk-form4_1771465767.xml · nonDerivative · entry 3

Senner Christopher J. · CIK 0001648367 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 976,092

F4 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.66 to $43.78. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.

F2 · balance_after: Includes 427,690 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 01:49 UTC
Haley Patrick J.EVP, Commercial
SaleCommon Stock 64,778 $43.50 $2,817,843.00
Disclosure

SEC source: 0000939767-26-000027 · wk-form4_1771465761.xml · nonDerivative · entry 3

Haley Patrick J. · CIK 0001692954 · EVP, Commercial

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 381,908

F4 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.50 to $43.64. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.

F2 · balance_after: Includes 381,908 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 01:49 UTC
Haley Patrick J.EVP, Commercial
SaleCommon Stock 3,036 $43.84 $133,098.24
Disclosure

SEC source: 0000939767-26-000027 · wk-form4_1771465761.xml · nonDerivative · entry 2

Haley Patrick J. · CIK 0001692954 · EVP, Commercial

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 446,686

F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.80 to $43.84. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.

F2 · balance_after: Includes 381,908 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 01:49 UTC
MORRISSEY MICHAELDirector · President and CEO
GiftCommon Stock 250,736 $0.00 $0.00
Disclosure

SEC source: 0000939767-26-000026 · wk-form4_1771465753.xml · nonDerivative · entry 5

MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 1,965,140

F4 · kind: On February 17, 2026, the Reporting Person gifted 250,736 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended.

F5 · balance_after: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 01:49 UTC
MORRISSEY MICHAELDirector · President and CEO
GiftCommon Stock 250,736 $0.00 $0.00
Disclosure

SEC source: 0000939767-26-000026 · wk-form4_1771465753.xml · nonDerivative · entry 4

MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,579,209

F4 · kind: On February 17, 2026, the Reporting Person gifted 250,736 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended.

F1 · balance_after: Includes 1,454,115 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
February 17, 2026 Filed Feb 20, 2026 00:18 UTC
Smith JulieDirector
Exercise / conversionOption (right to buy) · Derivative 42,422 $0.00 Strike: $18.19 $0.00
Disclosure

SEC source: 0000939767-26-000029 · wk-form4_1771546714.xml · derivative · entry 7

Smith Julie · CIK 0001557928 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 42,422 shares

Expires 2029-05-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option, representing the right to purchase a total of 42,422 shares of Common Stock, became fully exercisable on May 26, 2022.

Read SEC document
February 17, 2026 Filed Feb 20, 2026 00:18 UTC
Smith JulieDirector
SaleCommon Stock 42,422 $43.33 $1,838,145.26
Disclosure

SEC source: 0000939767-26-000029 · wk-form4_1771546714.xml · nonDerivative · entry 2

Smith Julie · CIK 0001557928 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,590

F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $44.30 to $44.44. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.

F1 · balance_after: Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.

Read SEC document
February 17, 2026 Filed Feb 20, 2026 00:18 UTC
Smith JulieDirector
Exercise / conversionCommon Stock 42,422 $18.19 $771,656.18
Disclosure

SEC source: 0000939767-26-000029 · wk-form4_1771546714.xml · nonDerivative · entry 1

Smith Julie · CIK 0001557928 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,012

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 01:49 UTC Tax withholdingCommon Stock 35,870 $43.92 $1,575,410.40
Disclosure

SEC source: 0000939767-26-000028 · wk-form4_1771465767.xml · nonDerivative · entry 2

Senner Christopher J. · CIK 0001648367 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,006,709

F3 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 16, 2025.

F2 · balance_after: Includes 427,690 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 01:49 UTC
Haley Patrick J.EVP, Commercial
Tax withholdingCommon Stock 31,483 $43.92 $1,382,733.36
Disclosure

SEC source: 0000939767-26-000027 · wk-form4_1771465761.xml · nonDerivative · entry 1

Haley Patrick J. · CIK 0001692954 · EVP, Commercial

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 449,722

F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 16, 2025.

F2 · balance_after: Includes 381,908 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 01:49 UTC
MORRISSEY MICHAELDirector · President and CEO
Tax withholdingCommon Stock 120,390 $43.92 $5,287,528.80
Disclosure

SEC source: 0000939767-26-000026 · wk-form4_1771465753.xml · nonDerivative · entry 3

MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,829,945

F3 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 16, 2025.

F1 · balance_after: Includes 1,454,115 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 01:49 UTC
Aftab DanaEVP, Research and Development
Tax withholdingCommon Stock 12,720 $43.92 $558,662.40
Disclosure

SEC source: 0000939767-26-000024 · wk-form4_1771465741.xml · nonDerivative · entry 2

Aftab Dana · CIK 0001959132 · EVP, Research and Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 693,897

F3 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of RSUs awarded on January 5, 2023.

F2 · balance_after: Includes 414,043 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 01:49 UTC
Aftab DanaEVP, Research and Development
Tax withholdingCommon Stock 26,485 $43.92 $1,163,221.20
Disclosure

SEC source: 0000939767-26-000024 · wk-form4_1771465741.xml · nonDerivative · entry 1

Aftab Dana · CIK 0001959132 · EVP, Research and Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 706,617

F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 16, 2025.

F2 · balance_after: Includes 414,043 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 01:48 UTC
Hefti BrendaSVP and General Counsel
Tax withholdingCommon Stock 5,430 $43.92 $238,485.60
Disclosure

SEC source: 0000939767-26-000022 · wk-form4_1771465726.xml · nonDerivative · entry 1

Hefti Brenda · CIK 0002097579 · SVP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 115,181

F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 16, 2025.

F2 · balance_after: Includes 95,956 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
February 13, 2026 Filed Feb 19, 2026 01:49 UTC SaleCommon Stock 34,278 $43.00 $1,473,954.00
Disclosure

SEC source: 0000939767-26-000028 · wk-form4_1771465767.xml · nonDerivative · entry 1

Senner Christopher J. · CIK 0001648367 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,042,579

F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.00 to $43.04. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.

F2 · balance_after: Includes 427,690 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
February 13, 2026 Filed Feb 19, 2026 01:49 UTC
MORRISSEY MICHAELDirector · President and CEO
Exercise / conversionOption (right to buy) · Derivative 494,700 $0.00 Strike: $21.31 $0.00
Disclosure

SEC source: 0000939767-26-000026 · wk-form4_1771465753.xml · derivative · entry 9

MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 494,700 shares

Expires 2028-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The option, representing the right to purchase a total of 494,700 shares of Common Stock, became fully exercisable on March 4, 2025.

Read SEC document
February 13, 2026 Filed Feb 19, 2026 01:49 UTC
MORRISSEY MICHAELDirector · President and CEO
Tax withholdingCommon Stock 369,606 $43.92 $16,233,095.52
Disclosure

SEC source: 0000939767-26-000026 · wk-form4_1771465753.xml · nonDerivative · entry 2

MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,950,335

F2 · shares: Represents a "net exercise" of an outstanding stock option to purchase 494,700 shares, and pursuant to which the Reporting Person received 125,094 shares of Common Stock. The Issuer withheld 369,606 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using the closing stock price on January 13, 2026 of $43.92.

F1 · balance_after: Includes 1,454,115 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
February 13, 2026 Filed Feb 19, 2026 01:49 UTC
MORRISSEY MICHAELDirector · President and CEO
Exercise / conversionCommon Stock 494,700 $21.31 $10,542,057.00
Disclosure

SEC source: 0000939767-26-000026 · wk-form4_1771465753.xml · nonDerivative · entry 1

MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,319,941

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 1,454,115 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
February 13, 2026 Filed Feb 19, 2026 01:49 UTC SaleCommon Stock 3,856 $43.79 $168,854.24
Disclosure

SEC source: 0000939767-26-000025 · wk-form4_1771465747.xml · nonDerivative · entry 1

Eckhardt Sue Gail · CIK 0001823769 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,524

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2025.

F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.89 to $43.89. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.

F3 · balance_after: Includes 17,524 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.

Read SEC document
February 13, 2026 Filed Feb 19, 2026 01:48 UTC
Oliver BobDirector
Exercise / conversionOption (right to buy) · Derivative 9,088 $0.00 Strike: $19.28 $0.00
Disclosure

SEC source: 0000939767-26-000023 · wk-form4_1771465734.xml · derivative · entry 4

Oliver Bob · CIK 0001694534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,118

Underlying: Common Stock · 9,088 shares

Expires 2030-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option, representing the right to purchase a total of 36,353 shares of Common Stock, became fully exercisable on May 31, 2023.

Read SEC document
February 13, 2026 Filed Feb 19, 2026 01:48 UTC
Oliver BobDirector
SaleCommon Stock 21,162 $43.90 $929,011.80
Disclosure

SEC source: 0000939767-26-000023 · wk-form4_1771465734.xml · nonDerivative · entry 3

Oliver Bob · CIK 0001694534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,120

F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.90 to $43.96. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.

F1 · balance_after: Includes 18,900 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.

Read SEC document
February 13, 2026 Filed Feb 19, 2026 01:48 UTC
Oliver BobDirector
SaleCommon Stock 9,088 $43.61 $396,327.68
Disclosure

SEC source: 0000939767-26-000023 · wk-form4_1771465734.xml · nonDerivative · entry 2

Oliver Bob · CIK 0001694534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,282

F1 · balance_after: Includes 18,900 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.

Read SEC document
February 13, 2026 Filed Feb 19, 2026 01:48 UTC
Oliver BobDirector
Exercise / conversionCommon Stock 9,088 $19.28 $175,216.64
Disclosure

SEC source: 0000939767-26-000023 · wk-form4_1771465734.xml · nonDerivative · entry 1

Oliver Bob · CIK 0001694534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,370

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 18,900 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.

Read SEC document
January 15, 2026 Filed Jan 17, 2026 00:02 UTC
Aftab DanaEVP, Research and Development
Tax withholdingCommon Stock 27,254 $45.23 $1,232,698.42
Disclosure

SEC source: 0000939767-26-000006 · wk-form4_1768608171.xml · nonDerivative · entry 2

Aftab Dana · CIK 0001959132 · EVP, Research and Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 733,102

F4 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of the PSUs awarded on April 3, 2023, for which the Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 15, 2026.

F3 · balance_after: Includes 491,096 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
January 15, 2026 Filed Jan 17, 2026 00:02 UTC
Aftab DanaEVP, Research and Development
GrantCommon Stock 119,578 $0.00 $0.00
Disclosure

SEC source: 0000939767-26-000006 · wk-form4_1768608171.xml · nonDerivative · entry 1

Aftab Dana · CIK 0001959132 · EVP, Research and Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 760,356

F1 · date: On April 3, 2023, the Reporting Person was granted a performance-based restricted stock unit award ("PSU") under the Exelixis, Inc. 2017 Equity Incentive Plan covering 68,331 shares of common stock (such shares, the "Target Shares"). The PSU generally vests as follows: (i) 50% of the eligible Target Shares vest upon the Compensation Committee's (the "Committee") certification of achievement of certain performance criteria; and (ii) 50% of the eligible Target Shares vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. In addition, the PSU provides for vesting of up to a maximum of 175% of the Target Shares depending on the timing and level of achievement of the performance criteria provided for under the PSU.

F2 · shares: On January 15, 2026, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 175% of the Target Shares subject to the PSU (such shares, the "Achieved Shares"). Accordingly, the Committee's certification on January 15, 2026 resulted in the immediate vesting of 50% of the Achieved Shares, and the remaining 50% of the Achieved Shares will vest on February 15, 2027, subject to the Reporting Person's continuous service through that date.

F3 · balance_after: Includes 491,096 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
January 15, 2026 Filed Jan 17, 2026 00:03 UTC
MORRISSEY MICHAELDirector · President and CEO
Tax withholdingCommon Stock 139,524 $45.23 $6,310,670.52
Disclosure

SEC source: 0000939767-26-000007 · wk-form4_1768608177.xml · nonDerivative · entry 2

MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,825,241

F4 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of the PSUs awarded on April 3, 2023, for which the Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 15, 2026.

F3 · balance_after: Includes 1,690,729 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
January 15, 2026 Filed Jan 17, 2026 00:03 UTC
MORRISSEY MICHAELDirector · President and CEO
GrantCommon Stock 548,073 $0.00 $0.00
Disclosure

SEC source: 0000939767-26-000007 · wk-form4_1768608177.xml · nonDerivative · entry 1

MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,964,765

F1 · date: On April 3, 2023, the Reporting Person was granted a performance-based restricted stock unit award ("PSU") under the Exelixis, Inc. 2017 Equity Incentive Plan covering 313,185 shares of common stock (such shares, the "Target Shares"). The PSU generally vests as follows: (i) 50% of the eligible Target Shares vest upon the Compensation Committee's (the "Committee") certification of achievement of certain performance criteria; and (ii) 50% of the eligible Target Shares vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. In addition, the PSU provides for vesting of up to a maximum of 175% of the Target Shares depending on the timing and level of achievement of the performance criteria provided for under the PSU.

F2 · shares: On January 15, 2026, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 175% of the Target Shares subject to the PSU (such shares, the "Achieved Shares"). Accordingly, the Committee's certification on January 15, 2026 resulted in the immediate vesting of 50% of the Achieved Shares, and the remaining 50% of the Achieved Shares will vest on February 15, 2027, subject to the Reporting Person's continuous service through that date.

F3 · balance_after: Includes 1,690,729 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
January 15, 2026 Filed Jan 17, 2026 00:02 UTC
Haley Patrick J.EVP, Commercial
Tax withholdingCommon Stock 32,332 $45.23 $1,462,376.36
Disclosure

SEC source: 0000939767-26-000005 · wk-form4_1768608166.xml · nonDerivative · entry 2

Haley Patrick J. · CIK 0001692954 · EVP, Commercial

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 481,205

F4 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of the PSUs awarded on April 3, 2023, for which the Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 15, 2026.

F3 · balance_after: Includes 443,784 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
January 15, 2026 Filed Jan 17, 2026 00:02 UTC
Haley Patrick J.EVP, Commercial
GrantCommon Stock 139,508 $0.00 $0.00
Disclosure

SEC source: 0000939767-26-000005 · wk-form4_1768608166.xml · nonDerivative · entry 1

Haley Patrick J. · CIK 0001692954 · EVP, Commercial

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 513,537

F1 · date: On April 3, 2023, the Reporting Person was granted a performance-based restricted stock unit award ("PSU") under the Exelixis, Inc. 2017 Equity Incentive Plan covering 79,719 shares of common stock (such shares, the "Target Shares"). The PSU generally vests as follows: (i) 50% of the eligible Target Shares vest upon the Compensation Committee's (the "Committee") certification of achievement of certain performance criteria; and (ii) 50% of the eligible Target Shares vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. In addition, the PSU provides for vesting of up to a maximum of 175% of the Target Shares depending on the timing and level of achievement of the performance criteria provided for under the PSU.

F2 · shares: On January 15, 2026, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 175% of the Target Shares subject to the PSU (such shares, the "Achieved Shares"). Accordingly, the Committee's certification on January 15, 2026 resulted in the immediate vesting of 50% of the Achieved Shares, and the remaining 50% of the Achieved Shares will vest on February 15, 2027, subject to the Reporting Person's continuous service through that date.

F3 · balance_after: Includes 443,784 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
January 15, 2026 Filed Jan 17, 2026 00:02 UTC Tax withholdingCommon Stock 40,459 $45.23 $1,829,960.57
Disclosure

SEC source: 0000939767-26-000004 · wk-form4_1768608160.xml · nonDerivative · entry 2

Senner Christopher J. · CIK 0001648367 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,076,857

F4 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of the PSUs awarded on April 3, 2023, for which the Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 15, 2026.

F3 · balance_after: Includes 494,177 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
January 15, 2026 Filed Jan 17, 2026 00:02 UTC GrantCommon Stock 149,474 $0.00 $0.00
Disclosure

SEC source: 0000939767-26-000004 · wk-form4_1768608160.xml · nonDerivative · entry 1

Senner Christopher J. · CIK 0001648367 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,117,316

F1 · date: On April 3, 2023, the Reporting Person was granted a performance-based restricted stock unit award ("PSU") under the Exelixis, Inc. 2017 Equity Incentive Plan covering 85,414 shares of common stock (such shares, the "Target Shares"). The PSU generally vests as follows: (i) 50% of the eligible Target Shares vest upon the Compensation Committee's (the "Committee") certification of achievement of certain performance criteria; and (ii) 50% of the eligible Target Shares vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. In addition, the PSU provides for vesting of up to a maximum of 175% of the Target Shares depending on the timing and level of achievement of the performance criteria provided for under the PSU.

F2 · shares: On January 15, 2026, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 175% of the Target Shares subject to the PSU (such shares, the "Achieved Shares"). Accordingly, the Committee's certification on January 15, 2026 resulted in the immediate vesting of 50% of the Achieved Shares, and the remaining 50% of the Achieved Shares will vest on February 15, 2027, subject to the Reporting Person's continuous service through that date.

F3 · balance_after: Includes 494,177 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
December 03, 2025 Filed Dec 5, 2025 23:51 UTC
Hefti BrendaSVP and General Counsel
GrantCommon Stock 30,170 $0.00 $0.00
Disclosure

SEC source: 0000939767-25-000141 · wk-form4_1764978676.xml · nonDerivative · entry 1

Hefti Brenda · CIK 0002097579 · SVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,611

F1 · date: Represents shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon the vesting of restricted stock units ("RSUs"). The RSUs were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 1/4th of the original number of shares subject to the RSU award on February 15, 2027 and thereafter as to 1/4th of the original number of shares subject to the RSU award on each February 15th until fully vested.

F1 · shares: Represents shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon the vesting of restricted stock units ("RSUs"). The RSUs were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 1/4th of the original number of shares subject to the RSU award on February 15, 2027 and thereafter as to 1/4th of the original number of shares subject to the RSU award on each February 15th until fully vested.

F2 · balance_after: Includes 110,745 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs.

Read SEC document
November 25, 2025 Filed Nov 26, 2025 21:05 UTC
Caligan Partners LPDirector · See Remarks
PurchaseCommon Stock 27,532 $43.12 $1,187,234.90
Disclosure

SEC source: 0000902664-25-005164 · ownership.xml · nonDerivative · entry 1

JOHNSON DAVID EDWARD · CIK 0001785557 · Director

Caligan Partners LP · CIK 0001727492 · Director · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,553,262

F1 · ownership.nature: This Form 4 is filed by David Johnson ("Mr. Johnson") and Caligan Partners LP ("Caligan") with respect to the securities held by Caligan Partners Master Fund LP ("Caligan Master Fund"), a Cayman Islands limited partnership, and managed accounts ("Caligan Accounts", together with the Caligan Master Fund, the "Caligan Fund and Accounts") to which Caligan serves as investment manager. Mr. Johnson is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.

Read SEC document
November 21, 2025 Filed Nov 25, 2025 00:47 UTC
Aftab DanaEVP, Research and Development
GiftCommon Stock 24,000 $0.00 $0.00
Disclosure

SEC source: 0000939767-25-000139 · wk-form4_1764031668.xml · nonDerivative · entry 1

Aftab Dana · CIK 0001959132 · EVP, Research and Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 640,778

F1 · kind: On November 21, 2025, the Reporting Person gifted 24,000 shares of Exelixis Inc. common stock ("Common Stock") to a donor-advised fund.

F2 · balance_after: Includes 431,306 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSU") and performance-based restricted stock units ("PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
November 21, 2025 Filed Nov 25, 2025 00:47 UTC
Haley Patrick J.EVP, Commercial
SaleCommon Stock 28,043 $42.58 $1,194,070.94
Disclosure

SEC source: 0000939767-25-000140 · wk-form4_1764031675.xml · nonDerivative · entry 4

Haley Patrick J. · CIK 0001692954 · EVP, Commercial

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 374,029

F5 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.51 to $42.71. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 5 to this Form 4.

F2 · balance_after: Includes 374,029 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and performance-based restricted stock units ("PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
November 20, 2025 Filed Nov 25, 2025 00:47 UTC
Haley Patrick J.EVP, Commercial
SaleCommon Stock 10,648 $41.77 $444,766.96
Disclosure

SEC source: 0000939767-25-000140 · wk-form4_1764031675.xml · nonDerivative · entry 3

Haley Patrick J. · CIK 0001692954 · EVP, Commercial

10b5-1 filing: No plan indicated

Ownership: Indirect · By 401(k)

Disclosed balance after: 0

F4 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $41.77 to $41.79. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.

Read SEC document
November 20, 2025 Filed Nov 25, 2025 00:47 UTC
Haley Patrick J.EVP, Commercial
SaleCommon Stock 23,539 $41.93 $986,990.27
Disclosure

SEC source: 0000939767-25-000140 · wk-form4_1764031675.xml · nonDerivative · entry 2

Haley Patrick J. · CIK 0001692954 · EVP, Commercial

10b5-1 filing: No plan indicated

Ownership: Indirect · By spouse

Disclosed balance after: 0

F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $41.87 to $41.99. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.

Read SEC document
November 20, 2025 Filed Nov 25, 2025 00:47 UTC
Haley Patrick J.EVP, Commercial
SaleCommon Stock 10,000 $42.11 $421,100.00
Disclosure

SEC source: 0000939767-25-000140 · wk-form4_1764031675.xml · nonDerivative · entry 1

Haley Patrick J. · CIK 0001692954 · EVP, Commercial

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 402,072

F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.10 to $42.13. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.

F2 · balance_after: Includes 374,029 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and performance-based restricted stock units ("PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
November 17, 2025 Filed Nov 20, 2025 01:11 UTC
Oliver BobDirector
GiftCommon Stock 1,044 $0.00 $0.00
Disclosure

SEC source: 0000939767-25-000138 · wk-form4_1763601062.xml · nonDerivative · entry 1

Oliver Bob · CIK 0001694534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,282

F1 · kind: On November 17, 2025, the Reporting Person gifted 1,044 shares of Exelixis, Inc. common stock ("Common Stock") to a not-for-profit organization.

F2 · balance_after: Includes 18,900 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.

Read SEC document
November 12, 2025 Filed Nov 14, 2025 00:12 UTC SaleCommon Stock 100,000 $43.55 $4,355,000.00
Disclosure

SEC source: 0000939767-25-000137 · wk-form4_1763079170.xml · nonDerivative · entry 1

PAPADOPOULOS STELIOS · CIK 0001202098 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,189,228

F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.55 to $43.58. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.

F2 · balance_after: Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.

Read SEC document
November 12, 2025 Filed Nov 14, 2025 00:12 UTC
MORRISSEY MICHAELDirector · President and CEO
GiftCommon Stock 80,000 $0.00 $0.00
Disclosure

SEC source: 0000939767-25-000136 · wk-form4_1763079162.xml · nonDerivative · entry 4

MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 1,714,404

F4 · kind: On November 12, 2025, the Reporting Person gifted 80,000 shares of Common Stock to a donor advised fund.

F5 · balance_after: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.

Read SEC document
November 12, 2025 Filed Nov 14, 2025 00:12 UTC
MORRISSEY MICHAELDirector · President and CEO
GiftCommon Stock 101,548 $0.00 $0.00
Disclosure

SEC source: 0000939767-25-000136 · wk-form4_1763079162.xml · nonDerivative · entry 3

MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 1,794,404

F2 · kind: On November 12, 2025, the Reporting Person gifted 101,548 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.

Read SEC document
November 12, 2025 Filed Nov 14, 2025 00:12 UTC
MORRISSEY MICHAELDirector · President and CEO
GiftCommon Stock 101,548 $0.00 $0.00
Disclosure

SEC source: 0000939767-25-000136 · wk-form4_1763079162.xml · nonDerivative · entry 2

MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,416,692

F2 · kind: On November 12, 2025, the Reporting Person gifted 101,548 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.

F3 · balance_after: Includes 1,416,692 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and performance-based restricted stock units ("PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each PSU represents a contingent right to receive one share of Common Stock.

Read SEC document
November 11, 2025 Filed Nov 14, 2025 00:12 UTC
MORRISSEY MICHAELDirector · President and CEO
GiftCommon Stock 160,000 $0.00 $0.00
Disclosure

SEC source: 0000939767-25-000136 · wk-form4_1763079162.xml · nonDerivative · entry 1

MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 1,692,856

F1 · kind: On November 11, 2025, the Reporting Person gifted 160,000 shares of Exelixis, Inc. common stock ("Common Stock") to the Bombora Rise Foundation.

Read SEC document
November 11, 2025 Filed Nov 14, 2025 00:12 UTC
Aftab DanaEVP, Research and Development
SaleCommon Stock 48,383 $42.50 $2,056,277.50
Disclosure

SEC source: 0000939767-25-000135 · wk-form4_1763079156.xml · nonDerivative · entry 1

Aftab Dana · CIK 0001959132 · EVP, Research and Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 664,778

F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.50 to $42.58. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.

F2 · balance_after: Includes 431,306 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSU"). Each RSU is the economic equivalent of one share of Common Stock.

Read SEC document
November 11, 2025 Filed Nov 14, 2025 00:12 UTC Exercise / conversionOption (right to buy) · Derivative 5,784 $0.00 Strike: $23.24 $0.00
Disclosure

SEC source: 0000939767-25-000134 · wk-form4_1763079150.xml · derivative · entry 4

Beckerle Mary C · CIK 0001520181 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,710

Underlying: Common Stock · 5,784 shares

Expires 2031-01-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option, representing the right to purchase a total of 30,848 shares of Common Stock, became fully exercisable on January 5, 2024.

Read SEC document
November 11, 2025 Filed Nov 14, 2025 00:12 UTC SaleCommon Stock 18,838 $41.90 $789,312.20
Disclosure

SEC source: 0000939767-25-000134 · wk-form4_1763079150.xml · nonDerivative · entry 3

Beckerle Mary C · CIK 0001520181 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,380

F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $41.81 to $42.02. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.

F1 · balance_after: Includes 21,380 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.

Read SEC document
November 11, 2025 Filed Nov 14, 2025 00:12 UTC SaleCommon Stock 5,784 $42.03 $243,101.52
Disclosure

SEC source: 0000939767-25-000134 · wk-form4_1763079150.xml · nonDerivative · entry 2

Beckerle Mary C · CIK 0001520181 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,218

F1 · balance_after: Includes 21,380 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.